CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $453,000 | +38.1% | 30,434 | +130.0% | 0.03% | +30.0% |
| Q1 2019 | $328,000 | -80.8% | 13,234 | -47.3% | 0.02% | -73.7% |
| Q4 2017 | $1,706,000 | -66.5% | 25,100 | -53.9% | 0.08% | -71.9% |
| Q2 2017 | $5,093,000 | -8.3% | 54,400 | -37.6% | 0.27% | +5.5% |
| Q1 2017 | $5,552,000 | +65.1% | 87,200 | +15.2% | 0.26% | +27.4% |
| Q4 2016 | $3,362,000 | +176.9% | 75,700 | +124.6% | 0.20% | -48.9% |
| Q3 2016 | $1,214,000 | -77.7% | 33,700 | -88.1% | 0.39% | +61.7% |
| Q1 2016 | $5,435,000 | +36.4% | 283,124 | +148.7% | 0.24% | +28.6% |
| Q4 2015 | $3,984,000 | +74.0% | 113,851 | +357.2% | 0.19% | +122.4% |
| Q3 2015 | $2,290,000 | -59.5% | 24,904 | -61.3% | 0.08% | -55.0% |
| Q2 2015 | $5,657,000 | +440.8% | 64,374 | +274.1% | 0.19% | +231.6% |
| Q3 2013 | $1,046,000 | -72.3% | 17,206 | -69.5% | 0.06% | -53.7% |
| Q2 2013 | $3,773,000 | – | 56,331 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |